You're sick, doctor's booked for weeks, so you fire up Copilot Health for advice. Sounds convenient—until it tells you to chill when you need the ER. Big Tech's new health bots are everywhere, but do they save lives or just sell data?
AUC in the low 0.9s. Unstoppable. Until the key feature — appointment time — vanished, and predictions turned random. That's the brutal wake-up call in healthcare data science.
Next time you're at the GP, an AI might be silently scribbling your symptoms. It's doubling doctors' focus on you—but at the risk of fuzzy memories and consent slip-ups.
Nearly $4 million. That's what NYC's public hospitals handed Palantir since last fall, just to walk away from a contract laced with privacy red flags. Meanwhile, across the pond, the UK's NHS is sleepwalking into deeper ties with the same controversial AI player.
Everyone tuned into JPM expecting the usual pharma deal chatter. Instead, NVIDIA's Jensen Huang dropped partnership bombs with Mayo, Illumina and more—pushing agentic AI as healthcare's savior. But after 20 years watching this circus, I'm wondering: who's really banking here?